Physician profile
Jason Bourque
NPI 1205060175
$4,303.12
in general payments reported to CMS, 2019-2025
34 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $407 · 2021: $602 · 2022: $484 · 2023: $839 · 2024: $844 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,466.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $671.22 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $455.60 | 2019-2025 | Botox, Lupron Depot |
| Teleflex LLC | $404.74 | 2021-2024 | Urolift |
| Sumitomo Pharma America, INC. | $396.50 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $274.98 | 2019-2025 | Erleada |
| Merck Sharp & Dohme LLC | $264.23 | 2020-2025 | Keytruda, Lynparza |
| Allergan, INC. | $198.81 | 2019-2022 | |
| Pfizer INC. | $164.61 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $154.25 | 2020-2025 | Provenge |
| Antares Pharma, INC. | $141.58 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Procept Biorobotics Corporation | $125.34 | 2023 | Aquabeam Robotic System |
| Boston Scientific Corporation | $113.27 | 2019-2023 | Ams 800 Artificial Urinary Sphincter |
| Olympus America INC. | $85.44 | 2025 | Itind System |
| Coloplast Corp | $84.82 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.42 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $72.38 | 2020 | |
| Progenics Pharmaceuticals, INC. | $60.41 | 2023-2025 | Pylarify |
| Laborie Medical Technologies Corp. | $52.99 | 2025 | |
| Endo Pharmaceuticals INC. | $51.99 | 2022-2024 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $49.89 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $47.92 | 2019-2025 | Adstiladrin |
| Myovant Sciences INC. | $47.14 | 2021-2022 | |
| Travere Therapeutics, INC. | $45.83 | 2021 | |
| Urogen Pharma, INC. | $45.15 | 2021-2025 | |
| Amgen INC. | $41.66 | 2021-2022 | |
| Axonics, INC. | $34.47 | 2021-2022 | |
| Accord Healthcare, INC. | $33.85 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $28.43 | 2022-2024 | Lynparza |
| Tolmar, INC. | $21.66 | 2023 | |
| Telix Pharmaceuticals | $13.67 | 2023 | Illuccix |
| Clarus Therapeutics INC. | $12.70 | 2021 | |
| Medtronic USA, INC. | $12.60 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $11.56 | 2021 | |
| Photocure INC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bourque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.